BUY BUTYLONE, also known as B-keto-N-methylbenzodioxolylbutanamine, is an entactogen, psychedelic, and stimulant psychoactive drug of the phenethylamine chemical class. It is the B-keto analogue of MBDB and the substituted methylenedioxyphenethylamine analogue of buphedrone.
BUY BUTYLONE (also known as β-keto-N-methylbenzodioxolylbutanamine, βk-MBDB, or B1) is a synthetic entactogen and stimulantof the phenethylamine and cathinone classes. Butylone is the β-keto analog of MBDB and the substituted methylenedioxy analogue of buphedrone.
As a designer drug, it is commonly sold on the street along with ethylone as a substitute or counterfeit for MDMA and methylone (all of which have collectively come to be referred to as “Molly”) due to methylone’s declining availability on the research chemicalmarket.
However, in spite of behavioral and pharmacological similarities between butylone and MDMA, the observed subjective effects of both substances are not completely identical.
Butylone has only a short history of human use and is reported to be less potent than its relatives methylone and ethylone as well as possessing more classic stimulant as opposed to entactogenic effects.
Psychedelics are drugs which alter the perception, causing a number of mental effects which manifest in many forms including altered states of consciousness, visual or tactile effects.
Stimulants excite the nervous system and increase physiological function.
Research chemicals are drugs with relatively little history of human use, and thus particular care should be taken if choosing to ingest them.
Read more on TripSit Wiki…
These drugs pose a higher risk of causing habit forming behaviour, take particular care with the amount and frequency they are taken.
drugs Originally synthesized by chemist Wayne E. Kenney, BAY is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotectiveeffects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury.
drugs has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury. It is a full agonist with around the same potency as CP 55,940 in animal studies, and has fairly high affinity for both CB1 and CB2 receptors, with Ki values of 2.91nM at CB1 and 4.24nM at CB2. It has been licensed to KeyNeurotek Pharmaceuticals for clinical development, and is currently in Phase II trials.But its development appears has stopped.
Originally synthesized by chemist Wayne E. Kenney, is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury.
Traumatic brain injury (TBI) is the most common cause of mortality and morbidity in adults under 40 years of age in industrialized countries. Worldwide the incidence is increasing, about 9.5 million people are hospitalized per year due to TBI, and the death rate is estimated to be more than one million people per year. Recently has been characterized as a structurally novel, selective and highly potent cannabinoid CB1/CB2 receptor agonist in vitro and in vivo with pronounced neuroprotective efficacy in a rat traumatic brain injury model, showing a therapeutic window of at least 5 h.